Navigation Links
Magstim 200

ProductsMagstim 200
Company Magstim Company US LLC
Item Magstim 200
Features 
Description Based upon the original Magstim design the new Magstim 200 monophasic transcranial stimulator draws upon the years of knowledge and expertise gathered in both the clinical and research environments. Resulting in an innovative design that will help further establish the new Magstim range as the system of preferred choice.
  • Ergonomic modular approach to design to complement any operating environment and facilitate simple upgradeability to future Magstim systems.
  • Remote control coil option offering complete 'single handed' system control, all stimulator control functions are available via active microprocessor controlled coils.
  • Intuitive highly visible user interface display incorporating online temperature and system status and online coil temperature indication as well as fully integrated safety diagnostic software on system 'power up'.
  • Total compatibility and flexibility through additional intelligent hardware, the Magstim 200 is fully compatible with all existing Magstim coils (remote control operation requires new coils).
  • New Microprocessor controlled system hardware for added system safety whilst also enabling remote software upgrades and PC interfacing capabilities via standard internal serial port
  • Info Magstim Company US LLC
    Customer Service: (781) 933-3933
    Web site: http://www.magstim-us.com

    Related medicine products :

    1. Disposable Bipolar Pencil - 18 Gauge Curved
    2. Disposable Bipolar Pencil - 18 Gauge Straight
    3. Disposable Bipolar Pencil - 23 Gauge Tapered Tip
    4. Storz Disposable Blades
    5. Disposable Ear Knife
    6. Disposable Medical Penlight
    7. Disposable Scalp Clip Applier
    8. Disposable Electrodes
    9. Mayfield Disposable Adult (plastic) Skull Pins
    10. Disposable 14 mm drill
    11. Disposable Trephine Blade (set of 5)
    TAG: Magstim
    The Contoured Wrist/Forearm Support provides comfort for post-surgical immobilization, post-fracture casting, and wrist sprains and strains.
    ManuTrain is an active wrist support that has optional features for increased stabilization.
    ...he Hand and Wrist Cryo/Cuff combines the therapeut...hemarthrosis and swelling, and cold to minimize pa...be repositioned for desired hand coverage. ,For a... cuff and can be removed if a wider range of motio...
    Bird and Cronin, Inc. is a leading manufacturer of Patient Footwear, Orthopedic Softgoods, and Specialty Patient Care Products. Our products are of the highest quality and available in the USA and In
    Medicine Products:
    (Date:7/25/2008)...ter financial results -, LAVAL, QC, July 25 /PRNe...AQ: DDSS) today announced that it will host a conf...to discuss its second quarter 2008,financial resul...financial,results via news release at approximatel...ce call by telephone, dial 416-646-3095 or,1-800-8...
    (Date:7/25/2008)...oviral therapy may be due to genetic factors , ... study challenges the long-held belief that the he...ability to restore itself after HIV patients are t...HAART). , From 50 percent to 90 percent of HIV-...travenous drug use is the main cause of both types...
    (Date:7/25/2008)...American Society for Gastrointestinal Endoscopy (A...y in the bariatric surgery patient. The rising pre...ccess in surgical interventions led to a marked in...ormed in the U.S., from 13,365 in 1998 to 102,794 ...reoperative patient and the postoperative patient,...
    (Date:7/25/2008)...mber of jobs created in the medical field slowed i...ent kind of slowdown: they laid off fewer people i... Seattle, WA (PRWEB) July 25, 2008 -- Thou... slowed in June overall, pharmaceutical companies ... music to the ears of sales representatives: fewer...
    Breaking Medicine News(10 mins):Health News:Labopharm to host conference call Friday, August 8, 2008 at 8:30 A.M. (ET) 2Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 2Health News:ASGE issues guidelines on the role of endoscopy in the bariatric surgery patient 3Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 2Health News:The MedZilla Report: June 2008 Employment Outlook for Biotech/Pharma/Health 3
    ... patient in the world Isabelle Dinoire, appears to...ng wine, and consuming chocolate cake in large qua... after being disfigured by a mauling she received ...ncouraging her to eat well after the weight she ha...
    ...oblem for women and any food givig respite is welc...s performed on rats and their bone cells. The comp...myl peptide did wonders and being treated with par...resoprtion. So this study can greatly help women a...
    ...ic used to treat respiratory tract problems such a.../. Three patients taking the drug was reported to ...k. The three cases of ketek adverse effects as be...edicine. The three patients did not have any liver...
    ...cted by Jerald Greenberg professor of management a...her College of Business stated// that pay cuts res.... The study was conducted in 4 hospitals in differ...ospitals the nurses received a pay cut which reduc...
    Other Medicine News:Health News:Pay Cut Leads To Increased Levels Of Insomnia Among Workers 2
    (Date:7/22/2008).../ -- Nonin Medical, a leading innovator,of physiol..., has entered,the clinical testing phase with its ... saturation. Today,s most common application for t... regional blood oxygenation,in the brain -- cerebr...m an ongoing clinical study at the,Duke University...
    (Date:7/22/2008)...pment Plan Completed Successfully, DUBLIN, Irelan...ation,plc (NASDAQ: AMRN ) today announced that th...Food and Drug Administration (FDA) to discuss the,...t of,hypertriglyceridemia. Following these discuss...R101 in hypertriglyceridemia., Dr. Declan Doogan,...
    (Date:7/22/2008)...ms Tyrima Exhibits Excellent Drug-Like ...port Initiation of Phase II Clinical Trials -, RE...- CeNeRx BioPharma,Inc., a clinical stage company...nts for diseases of the central nervous system, to...Tyrima(TM) into Phase II trials for the,treatment ...
    (Date:7/22/2008)...e Importance to Patients of Passing a ...ND, Va., July 22 /- Insmed ...ologics and biopharmaceuticals, today,announced th...ent at a,Congressional briefing on Friday, July 25...lishing an approval pathway for follow-on,biologic...
    Breaking Medicine Technology:Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 2Amarin Proceeding to Phase 3 With AMR101 for Hypertriglyceridemia 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 2Insmed CEO to Present at Congressional Briefing on Follow-On Biologics 3Penn biochemist receives NIH New Innovators Award 705 1Penn biochemist receives NIH New Innovators Award 705 2Operation Mend Offers New Hope for Wounded Warriors 3031 1Operation Mend Offers New Hope for Wounded Warriors 3031 2Operation Mend Offers New Hope for Wounded Warriors 3031 3UNC faculty and students to develop plan to get clean water in poorer homes 3030 1UNC faculty and students to develop plan to get clean water in poorer homes 3030 2UNC faculty and students to develop plan to get clean water in poorer homes 3030 3Primitive Plants Have Complex Sex Life 3028 1
    ...007, SAN DIEGO, and SEOUL, South Korea, April 13,/...nc. and LG Life,Sciences, Ltd., presented data fro...retains potency against multiple mutant strains of...mivudine,adefovir, entecavir or telbivudine, duri...g of the European Association for the Study,of the...
    ... B e-Antigen,(HBeAg)-Negative Patients Achieved Un...PRINCETON, N.J., April 13, 2007 /PRNewswire-FirstC...ed data from a cohort of,nucleoside-naive HBeAg-ne...n=99). These data showed that patients who,experie...blood,after interruption of treatment with BARACLU...
    Other Medicine Technology:ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 2ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 3ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 4ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 5ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 6Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 2Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 3Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 4Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 5